Subjects
Public Msgs
Members
Member Profiles
My Private Msgs
Yahoo! Quote
Advanced Search
[
sign in
]
Register
Biotech / Medical
|
Biotech Valuation
Previous 10
|
Next 10
To:
tom pope
who wrote (
38317
)
5/23/2012 7:41:02 AM
From:
IRWIN JAMES FRANKEL
 
of 40264
Weighty evidence, indeed.
:-)
ij
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
To:
scaram(o)uche
who wrote (
38310
)
5/23/2012 2:56:21 PM
From:
nigel bates
 
of 40264
>If it's smooth, don't let them touch it!!!!<
I'm tempted to ask, how else would they know ? :)
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
To:
BulbaMan
who wrote (
38304
)
5/23/2012 4:42:22 PM
From:
software salesperson
 
of 40264
here is hans rosling on worldwide prostate cancer statistics and, among other things, the correlation between rising income and overdiagnosis:
gapminder.org
he is one of the world's leading thinkers. for those who may be unfamiliar with his fascinating TED talks and his visualization software, here is his bio:
en.wikipedia.org
his site has similar videos on other cancer types:
gapminder.org
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (1)
To:
software salesperson
who wrote (
38322
)
5/23/2012 6:27:49 PM
From:
tom pope
 
of 40264
Very interesting.
Clearly the decision to treat or not must be on a case by case as I think Rosling suggests. I had a PSA that went from under 2 to 6 in a year. On biopsy, Gleason score was a 7. I saw 4 specialists ( 1standard radiation, 1 HIFU, 1 Davinci and the Duke stereotactic study). Not one of the specialists recommended watchful waiting.
I decided to go with the Duke program, and am very glad I did.
.
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (2)
To:
tom pope
who wrote (
38323
)
5/23/2012 10:08:16 PM
From:
Robohogs
 
of 40264
They get paid not to wait, Tom.
Jon
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (1)
To:
Robohogs
who wrote (
38324
)
5/23/2012 11:32:44 PM
From:
tom pope
 
of 40264
You're a trifle cynical, methinks.
The nice thing about a Gleason 7 in the context of watchful waiting is that you may not have long to wait.
Saves time.
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (1)
To:
tom pope
who wrote (
38323
)
5/23/2012 11:37:22 PM
From:
Biomaven
 
of 40264
Good thing you didn't go with them Death Panel folks:
online.wsj.com
This was an interesting (if strangely designed) study:
medpagetoday.com
As I said before, I think MDV3100 prior to surgery makes a lot of sense.
Peter
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (3)
To:
tom pope
who wrote (
38325
)
5/24/2012 12:32:27 AM
From:
Robohogs
 
of 40264
Lol. I have been accused of that in the past. I'm glad it all worked out for you!
Jon
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
To:
Biomaven
who wrote (
38326
)
5/24/2012 12:35:31 AM
From:
Robohogs
 
of 40264
For death panel politics, go check out an editorial about the Lockerbie bomber. Apparently, they let him out of jail because he only had about a month to live. When he got to Libya, the treatment was so much better that he lived an additional three years. Almost nothing was covered under the Scottish system. I cannot remember where I read this editorial, but it made for interesting reading.
Jon
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
|
Read Replies (1)
To:
Robohogs
who wrote (
38328
)
5/24/2012 1:00:29 AM
From:
Robohogs
 
of 40264
online.wsj.com
Jon
Biotech Valuation | Stock Discussion Forums
Share
Recommend
| Keep |
Reply
|
Mark as Last Read
Previous 10
|
Next 10
Home
Mail
Hot
SubjectMarks
PeopleMarks
Keepers
Settings
Terms Of Use
Contact Us
Copyright/IP Policy
Privacy Policy
About Us
FAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.